IP Library Granted Patent US 10,639,157
Granted Patent B2
US 10,639,157 · App. 15/921,583 · Granted May 5, 2020

Demineralized bone fiber composition for use in minimally invasive surgery

Inventors: Nelson L. Scarborough (Andover, MA); Andrew J. Carter (Stow, MA); Bradley E. Patt (Northridge, CA)
Assignee: Theracell, Inc.
A61F2/2846A61F2/28A61F2002/285A61F2002/2835A61F2002/3096A61F2002/30225A61F2002/30235A61F2002/30588A61F2310/00359
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,639,157
App. No.
15/921,583
Granted
May 5, 2020
Kind
B2
Abstract

A bone implant composition and methods thereof include bone material made into various implant shapes including a cylinder having an outermost layer and an inner layer completely surrounded by the outermost layer. The bone implant compositions and methods include a bag or cylindrical tube made from a bone material which may be filled with additional bone material.

Claims (17)

1. A method of making a bone implant from a sheet of demineralized bone fibers (DBF) comprising a plurality of elongated bone fibers cut from demineralized bone in a direction parallel to the orientation of collagen fibers, the method comprising:

providing the DBF into a sheet mold to form a sheet of DBF; and

processing the sheet of DBF by:

i) rolling the sheet of DBF to form a cylindrical bone implant or a hollow tube bone implant; or

ii) bonding a first sheet of DBF with a second sheet DBF to form a bone implant bag,

wherein the hollow tube bone implant or the cylindrical bone implant has a length of from about 1 cm to about 30 cm and a diameter of from about 3 mm to about 15 mm.

2. The method of claim 1 , further comprising adding a second bone material to the sheet of DBF prior to rolling the sheet of DBF, the second bone material selected from synthetic bone graft substitute, allograft bone chips, xenograft bone chips, and/or demineralized bone matrix (DBM).

3. The method of claim 1 , wherein rolling the sheet of DBF to form a cylindrical bone implant comprises using a cigarette roller technique.

4. The method of claim 1 , wherein rolling the sheet of DBF to form a hollow tube bone implant comprises hand rolling the sheet around a mandrel.

5. The method claim 4 , wherein the mandrel has an oval cross section.

6. The method of claim 4 , further comprising heating the cylindrical bone implant or the hollow tube bone implant at between 30° to 70° Celsius for 1 minute up to 180 minutes.

7. The method of claim 6 , further comprising filling the hollow tube bone implant with synthetic bone graft substitute, allograft bone chips, xenograft bone chips, and/or demineralized bone matrix (DBM), wherein the filling occurs after heating.

8. The method of claim 1 , wherein the bonding of the first sheet of DBF with the second sheet of DBF to form a bone implant bag comprises annealing together three of four sides of the first sheet and the second sheet forming a cavity therebetween.

9. The method of claim 1 , wherein the bone implant bag has a length from about 5 cm to about 11 cm and a width from about 5 cm to about 11 cm.

10. A method of making a bone implant bag from a sheet of demineralized bone fibers (DBF) comprising:

providing the DBF into a sheet mold to form a sheet of DBF; and

bonding a first sheet of DBF with a second sheet DBF to form a bone implant bag.

Assignments (8)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 26, 2025
From: THERACELL, LLC
To: ARTERIOCYTE MEDICAL SYSTEMS, INC.
Reel/Frame 072388/0197 →
SECURITY INTEREST Recorded Sep 18, 2025
From: ISTO TECHNOLOGIES II, LLC; ADVANCED BIOLOGICS LLC,; ARTERIOCYTE MEDICAL SYSTEMS, INC.; THERACELL, LLC
To: GOLUB CAPITAL MARKETS LLC
Reel/Frame 072300/0216 →
RELEASE OF SECURITY INTEREST Recorded Sep 16, 2025
From: BARINGS FINANCE LLC, AS COLLATERAL AGENT
To: ARTERIOCYTE MEDICAL SYSTEMS, INC.; ISTO TECHNOLOGIES II, LLC; THERACELL, LLC; ADVANCED BIOLOGICS, LLC; BIOLOGICA TECHNOLOGIES, LLC
Reel/Frame 072274/0408 →
RELEASE OF SECURITY INTEREST Recorded Oct 18, 2023
From: TWIN BROOK CAPITAL PARTNERS, LLC
To: ISTO TECHNOLOGIES II, LLC
Reel/Frame 065269/0604 →
SECURITY INTEREST Recorded Oct 18, 2023
From: ARTERIOCYTE MEDICAL SYSTEMS, INC.; ISTO TECHNOLOGIES II, LLC; THERACELL, LLC; ADVANCED BIOLOGICS, LLC; BIOLOGICA TECHNOLOGIES, LLC
To: BARINGS FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 065271/0059 →
CHANGE OF NAME Recorded Oct 11, 2023
From: THERACELL, INC.
To: THERACELL, LLC
Reel/Frame 065219/0102 →
SECURITY INTEREST Recorded Apr 4, 2022
From: THERACELL, INC.
To: TWIN BROOK CAPITAL PARTNERS, LLC, AS AGENT
Reel/Frame 059486/0202 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 30, 2020
From: SCARBOROUGH, NELSON L.; CARTER, ANDREW J.; PATT, BRADLEY E.
To: THERACELL, INC.
Reel/Frame 051676/0771 →
Continuity (2)
Provisional Application 62471284 · Mar 14, 2017
Related Publication 20180263779A1 · Sep 20, 2018